Furthermore, a significant decrease in C3 levels was seen after the VLCD, whereas no differences were shown between obese subjects with or without T2DM, indicating that C3 might be a marker of obesity rather than T2DM. This evidence concerns the gene C3 and obesity due to melanocortin 4 receptor deficiency.